07:00 , Sep 29, 2014 |  BC Week In Review  |  Company News

Ligand, CURx Pharmaceuticals deal

Ligand expanded an August 2013 deal with CURx to include the development and commercialization of Ligand's Captisol-enabled lamotrigine program. Under the expanded deal, Ligand will receive an undisclosed upfront payment and be eligible to...